Has James Reeves received payments from drug or device companies?

Yes. Drug and device makers reported $40,094 in general payments to James Reeves across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Reeves did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Reeves come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Reeves

Medical Oncology · Fort Myers, FLNPI 1447233986

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $27,528 of the $40,094 with a category attached, or 68.7%. 51 manufacturers reported payments, led by Eisai Inc. at 45.1% of the total. Reporting peaked in 2019 at $30,172 and has fallen 99.9% since, to $34 in 2024.

$40,094in general payments, 2019–2025

Across 203 payments — averaging $197.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eisai Inc.$18K
Johnson & Johnson$13K
AstraZeneca$870
E.r. Squibb & Sons, L.L.C.$837
Sanofi$788
Exelixis Inc.$567
plus $6K from 45 others

$7,077,800in research payments, 2019–2025

Across 868 payments — averaging $8154.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$994K
Merck$952K
Eli Lilly$917K
E.r. Squibb & Sons, L.L.C.$824K
Genentech, Inc.$608K
Sanofi US Services Inc.$544K
plus $2.2M from 15 others

What the payments were for

Consulting fees$1210%
Speaking & faculty fees$27,52869%
Travel & lodging$2,6117%
Food & beverage$9,02823%
Education$8062%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eisai Inc.	22	$18,100
Johnson & Johnson	16	$12,512
AstraZeneca	10	$870
E.r. Squibb & Sons, L.L.C.	9	$837
Sanofi	13	$788
Exelixis Inc.	7	$567
Bristol Myers Squibb	8	$476
Daiichi Sankyo Inc.	8	$459
W. L. Gore & Associates, Inc.	3	$436
Merck	11	$410
Foundation Medicine, Inc.	3	$354
Clovis Oncology, Inc.	3	$325
Novartis	6	$322
Pharmacyclics LLC, An Abbvie Company	3	$283
Genentech USA, Inc.	6	$247
Adaptive Biotechnologies Corporation	2	$219
Epizyme, Inc.	2	$212
Jazz Pharmaceuticals Inc.	2	$197
Seagen Inc.	4	$178
Amgen	6	$157
Incyte Corporation	5	$157
Dendreon Pharmaceuticals LLC	2	$142
Puma Biotechnology, Inc.	2	$134
Acrotech Biopharma Inc.	1	$121
Nanostring Technologies, Inc.	3	$116
AbbVie	2	$115
Verastem, Inc.	1	$109
Novocure Inc.	1	$108
ADC Therapeutics America, Inc.	1	$105
Bayer	2	$101
EMD Serono, Inc.	1	$100
Array Biopharma Inc	2	$98
Pfizer	7	$96
Tesaro, Inc.	3	$95
Sirtex Medical Inc	1	$94
Rigel Pharmaceuticals, Inc.	1	$91
Veracyte, Inc.	6	$59
Lilly USA, LLC	2	$44
Beigene USA, Inc.	3	$44
Karyopharm Therapeutics Inc.	2	$32
Dova Pharmaceuticals	1	$31
Heron Therapeutics, Inc.	1	$23
GSK	1	$19
Gilead	1	$18
Lightforce Orthodontics, Inc.	1	$16
Aurobindo Pharma USA, Inc.	1	$13
Helsinn Therapeutics (U.S.), Inc.	1	$13
Spectrum Pharmaceuticals Inc.	1	$13
Blueprint Medicines Corporation	1	$13
Astellas Pharma US Inc	1	$13
Octapharma USA, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,094 in reported general payments places this provider in the 80th percentile of 507 medical oncology providers in Florida.

See all medical oncology providers in Florida →

Other medical oncology in Fort Myers

Lowell HartFort Myers$257K
Syed ZafarFort Myers$76K
Neil LoveMiami$5.6M
Mahdi TahaBoca Raton$1.7M
Raji ShameemOrlando$1.3M
Mohammad JahanzebBoca Raton$1.3M
Michel VelezOrlando$927K
Yuanbin ChenOrlando$810K
Reshma MahtaniPlantation$608K
Rebecca MorooseOrlando$543K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →